Global Biophotonics Market Size To Worth USD 149 Billion By 2030 | CAGR 12 %

Category: Healthcare

RELEASE DATE Nov 2022
REPORT ID SI1346

A PHP Error was encountered

Severity: Notice

Message: Undefined variable: table

Filename: press/detail.php

Line Number: 118

Backtrace:

File: /home/admin/web/sphericalinsights.com/public_html/application/views/press/detail.php
Line: 118
Function: _error_handler

File: /home/admin/web/sphericalinsights.com/public_html/application/views/layouts/master_header_footer.php
Line: 720
Function: view

File: /home/admin/web/sphericalinsights.com/public_html/application/controllers/Press.php
Line: 89
Function: view

File: /home/admin/web/sphericalinsights.com/public_html/index.php
Line: 295
Function: require_once

Global Biophotonics Market worth $149 billion by 2030

According to a research report published by Spherical Insights & Consulting, the Global Biophotonics Market Size to grow from USD 54 billion in 2021 to USD 149 billion by 2030, at a Compound Annual Growth Rate (CAGR) of 12% during the forecast period.

biophotonics markert

Get more details on this report -

Request Free Sample PDF

The biophotonics market has grown due to the growing elderly population, increasing prevalence of chronic diseases, expanding government efforts, rising healthcare reforms, and integration of IT into healthcare applications.

 

Browse 52 market data Tables and 62 Figures spread through 200 Pages and in-depth TOC on  “Global Biophotonics Market Size, Share, and COVID-19 Impact Analysis, By End-User (Tests and Components, Medical Therapeutics, Medical Diagnostics, and Non- medical Application), By Application (See-Through Imaging, Inside Imaging, Spectro Molecular, Analytics Sensing, Light Therapy, Surface Imaging, and Biosensors), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2021 – 2030.” View a detailed Table of Content here– https://www.sphericalinsights.com/reports/biophotonics-market

 

The COVID-19 pandemic has made an adverse impact on credit portfolios. There has been an unprecedented rise in unemployment and disruption in economic activity, putting a strain on the solvency of customers and companies. Central banks have taken a proactive approach by injecting liquidity into the market by lowering interest rates and asset purchase programs. Managing and monitoring credit, market, liquidity, and operational risk across financial markets were hard enough with ongoing geopolitical tensions, international trade wars, and the occasional hurricanes and earthquakes. The current pandemic situation has forced chief risk officers and their teams to recalibrate old assumptions and models used to manage and monitor risk. COVID-19’s global impact has shown that interconnectedness plays an important role in international cooperation. As a result, many governments started rushing toward identifying, evaluating, and procuring reliable solutions powered by AI.

 

The non-medical application segment to account for the largest market size during the forecast period

Based on the end-user, the global biophotonics market is categorized into Tests and Components, Medical Therapeutics, Medical Diagnostics, and Non- medical Applications.  The non-medical application segment to account for the largest market size during the forecast period.  Because a variety of end users, including healthcare providers, instrument manufacturers, medical institutions, and research labs, have adopted it. However, due to its environmental screening and monitoring capabilities, the non-medical application is anticipated to become more popular over the forecast period. The biophotonics market is expected to be greatly driven by the increase in research on pathogens, exposures in agricultural food products, ongoing blood monitoring, and prevention of unlawful data visualization. Additionally, the study of DNA, proteins, and other significant molecules, as well as molecular pathways, makes use of biophotonics.

 

The See-through imaging electronics segment to hold a higher CAGR during the forecast period

Based on the application, the biophotonics market is categorized into See-Through Imaging, Inside Imaging, Spectro Molecular, Analytics Sensing, Light Therapy, Surface Imaging, and Biosensors.  The See-through imaging electronics segment to hold a higher CAGR during the forecast period. Due to the constant need for radical non-invasive surgical techniques in several medical specialties, including cardiology, neurology, brain imaging, and oncology, the see-through imaging segment held the biggest market share. Over the past ten years, there have been significant advancements in the field of transparent imaging techniques, particularly in the areas of drug development and medical diagnosis. A crucial component of biomedical research, see-through imaging has also emerged as a useful tool for in-vitro and in-vivo imaging.

 

Asia-Pacific to hold a higher CAGR during the forecast period.

The Global Biophotonics Market has been segmented into five major regions:  North America, Europe, Asia-Pacific, South America, The Middle East and Africa.

NA

Get more details on this report -

Request Free Sample PDF

North America is estimated to account for the highest market share in 2022. Due to the booming R&D efforts, rising healthcare industry spending, and accessibility to top-notch infrastructure. In addition, the regional market of North America is anticipated to increase over the coming years as a result of the rising elderly population and the rising number of cancer patients.

 

Major vendors in the Global Biophotonics Market include Thermo Fisher Scientific, NU Skin Enterprises, Becton, Dickinson and Company, Glenbrook Technologies, Hamamatsu Photonics KK, Olympus Corporation, Carl Zeiss AG, Oxford Instruments PLC, Zenalux Biomedical Inc., and PerkinElmer.

 

Contact Us: https://www.sphericalinsights.com/contact-us

 

 

Frequently Asked Questions (FAQ)

  • What is the market size of the Biophotonics market?
    As per Spherical Insights, the size of the Biophotonics market was valued at USD 54 billion in 2022 to USD 149 billion by 2030.
  • What is the market growth rate of the Biophotonics market?
    The Biophotonics market is growing at a CAGR of 12% from 2022 to 2030.
  • Which country dominates the Biophotonics market?
    North America emerged as the largest market for Biophotonics.
  • Who are the key players in the Biophotonics market?
    Key players in the Biophotonics market are Thermo Fisher Scientific, NU Skin Enterprises, Becton, Dickinson and Company, Glenbrook Technologies, Hamamatsu Photonics KK, Olympus Corporation, Carl Zeiss AG, Oxford Instruments PLC, Zenalux Biomedical Inc., and PerkinElmer.
  • Which factor drives the growth of the Biophotonics market?
    The increasing geriatric population is expected to drive the market's growth over the forecast period.

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies